The TAC3 gene helps make a brain signaling molecule called neurokinin B, which supports the hormone messages between the brain and the ovaries or testes. This gene helps your body start and maintain puberty and fertility. If the gene does not work properly, puberty may be very delayed or absent, periods may not begin, testicular growth may be limited, and fertility can be reduced. TAC3 is mainly discussed in specialist care and is not a gene with broad public attention.
What is a gene?
A gene is a piece of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes contain the information needed to produce proteins, which do much of the work inside cells. Other genes mainly help direct when, where, and how strongly certain processes take place. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to explore this topic more deeply, you can learn more in the LearnHub.
Overview
TAC3Gene function
What if the gene works
The TAC3 gene helps make neurokinin B, a brain signaling protein. This signal helps control the release of reproductive hormones and supports the normal timing of puberty and fertility.
Risk
What if the gene does not work
Variants in the TAC3 gene can disrupt signaling needed to start puberty. More disruptive variants often cause delayed or absent puberty and reduced fertility, while milder variants may lead to later puberty with a less marked effect on hormone levels.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the TAC3 gene does not currently point to a TAC3-specific treatment or drug choice in clinical guidelines. Care usually relies on standard hormone replacement or fertility treatment plans rather than a TAC3-targeted medicine, and the TAC3 pathway is mainly being studied as a broader drug target in reproductive and hormone-related research.
Conditions associated with TAC3
Gene function
What if the gene works
In the brain, the TAC3 gene helps nerve cells send brief chemical messages. These messages are especially important in the hypothalamus, the area that helps time hormone release. Knowing how the TAC3 gene works helps explain how the body coordinates puberty and ongoing reproductive function.
The TAC3 gene provides instructions for making neurokinin B, a small chemical messenger used by certain nerve cells. This messenger helps nearby cells pass along signals in a controlled, timed way.
In the hypothalamus, neurokinin B helps coordinate pulses of gonadotropin releasing hormone (GnRH, a signal that starts reproductive hormone release). This timing supports steady communication between the brain and the ovaries or testes.
This signaling helps regulate the release of luteinizing hormone and follicle stimulating hormone, which guide ovulation, testosterone production, and sperm development. When the TAC3 gene is working normally, these hormone rhythms stay more organized and predictable.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TAC3 gene can change the neurokinin B precursor so the final signaling peptide is made in smaller amounts, processed poorly, or not released properly. More disruptive variants may sharply reduce or stop signaling, while milder variants can leave some activity. This range helps explain how TAC3 gene variants affect puberty and reproductive hormone signaling, with more severe loss of function often linked to earlier or more noticeable symptoms.
How variants are linked to conditions
Pathogenic variants in the TAC3 gene cause a rare inherited form of congenital hypogonadotropic hypogonadism, often described as TAC3-related hypogonadotropic hypogonadism. This condition is linked to absent or delayed puberty, low sex hormone levels, and fertility problems. Many people with TAC3-related hypogonadotropic hypogonadism have a normal sense of smell, although features can vary from person to person.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the TAC3 gene. For many living with a TAC3 gene change, risk is mainly shaped by the specific variant itself rather than by lifestyle or environmental factors, and a doctor or genetic counselor can help explain personal risk.
Inheritance of TAC3 variants
TAC3-related conditions are usually inherited in an autosomal recessive pattern. This means a person inherits one TAC3 gene variant from each parent, and parents who each carry one variant are typically unaffected carriers. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, how TAC3 gene variants are inherited often becomes clear only after more than one family member is tested or diagnosed.
What does my TAC3 result mean for my family?
For TAC3, the best-known family pattern is recessive, which means close relatives may be healthy carriers without knowing it. Brothers or sisters could also have the same condition, especially if they have delayed or absent puberty, while parents are often unaffected carriers. Family members may want to talk with a genetics professional about what this result means in their own branch of the family.
Genetic information
Genetic testing
How you find out about variants
TAC3 genetic testing uses a blood or saliva sample. A lab reads the DNA in the TAC3 gene, often as part of a delayed puberty or hypogonadotropic hypogonadism panel, to look for variants. Results may identify a pathogenic variant, a harmless change, or a variant of uncertain significance.
When should I consider getting a genetic test?
If puberty is very delayed or does not start, especially when hormone tests suggest the brain is not sending the usual signals to the ovaries or testes, TAC3 testing may be part of the evaluation. It can also be considered when this pattern runs in the family or when infertility is linked to the same hormone problem.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains varies by the condition and the kind of variant involved. Other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood as one part of overall care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Small differences in the body's drug handling, such as how a medicine is broken down or how strongly the body responds to it, are common. These differences can influence how well a treatment works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It studies patterns between genes and drugs to clarify why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To learn more about this topic, you can explore the LearnHub.
Drugs influenced by the TAC3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or medication response, so general concerns about medicines or side effects are best discussed with your doctor or pharmacist.
History
The TAC3 gene entered medical genetics through research on a small brain signaling molecule called neurokinin B. In recent decades, awareness of this gene’s role has grown as studies of delayed or absent puberty pointed researchers toward changes in this pathway. A major step came in 2009, when pathogenic variants in the TAC3 gene were linked to inherited forms of hypogonadotropic hypogonadism, helping explain why some families shared a similar pattern of pubertal delay. From these first observations, research expanded steadily to include the TAC3 gene in the broader story of reproductive endocrinology. This work helped move the field from describing symptoms alone to identifying the genetic basis behind them.